trapezoid glp 1 Weight Loss Medications Compound Tirzepatide Vs GLP-1 Medications:

2024;20(1):e130423215752

Completing the intake does not guarantee that a prescription will be issued

1 Obesity and related conditions cost the U.S

As GLP-1 RAs are contraindicated for people with gastrointestinal disease, pancreatitis, or a family history of mutations in multiple endocrine neoplasia type 2/medullary thyroid carcinoma (MEN2/MTC), SGLT2i is the preferred treatment for these patients groups

They mimic the action of glucagon-like peptide-1, a hormone that: Slows gastric emptying Reduces appetite Stimulates insulin secretion Lowers blood glucose levels Due to their appetite-suppressing and metabolic benefits, they are now frequently prescribed off-label for weight loss and increasingly used by women with PCOS or obesity-related infertility